Issue 10 2024, Acquisition International | 23 CFO of the Year 2024 (Switzerland): Jaroslaw Krupa stablished in 2012, Mera Pharma plays a significant role in improving and extending the life of an ever-increasing number of patients around the world. The company has been duly authorised by Swissmedic to manufacture and distribute both active pharmaceutical ingredients and pharmaceutical finished products. In the pharmaceutical industry, it is crucial to remain up to date with the latest regulations and practices, as well as maintaining a prominent level of transparency with clientele and partners. The Mera Pharma plant is subject to official periodic inspections as it strives to retain the required GMP level. Due to the advantageous nature of its products, Mera Pharma seeks out ways to expand its reach to help as many individuals as possible. “The Mera Pharma group is continuously working on expanding its network with both manufacturers and brand owners in Europe,” says Jaroslaw, “as well as with the chains of importers and distributors of pharmaceuticals from the public and private sector in the Middle East.” Mera Pharma takes a client-centric approach to its operations, striving to exceed its customers expectations by delivering high-quality generic products, alongside exceptional services, and a close attention to binding laws, regulations, and instructions. The company leverages its passion and commitment to its customers to discover, develop, and deliver the most cutting-edge, affordable, high quality products that promise to enrich their quality of life. A leader in modern solutions, Mera Pharma offers a wide range of food supplement products containing essential vitamins, minerals, and trace elements, customers can rebalance their body and eliminate deficiencies. The company also offers an array of specially formulated skincare products that provide both prevention and proper skin care, each designed for a particular dermatological problem. As for medical devices, Mera Pharma has developed eye drops, nasal spray, synovial fluid replacement, and stick packs to reduce heartburn. “Mera Pharma is not only a company,” Jaroslaw tells us. “It is a spirit of different components, like a good team with a family feeling. Every day brings new challenges and experiences. Mera Pharma is a vision and its own philosophy.” Jaroslaw Krupa is the CFO of Mera Pharma and has held this position since 2016. He began his illustrious career in the financial sector in 1998. Over the years, Jaroslaw has worked for a number of prestigious companies, including Allianz Suisse, Hogg Robinson Group Switzerland, and American Express. Across these companies, he held the roles of Senior Accountant, Finance Specialist, Head of Accounting and Tax, and CFO. Upon becoming an external consultant for Mera Pharma and Med Products, Jaroslaw proved very effective in his position and drove great success through the collaboration. This led to the company owners desiring Jaroslaw to work for Med Pharma on an employee basis, making him CFO of both companies. As the CFO, Jaroslaw is responsible for managing the financial actions of a company, with his duties including tracking cash flow, financial planning, analysing strengths and pain points, proposing corrective actions, and making decisions related to financial risks and investments. His extensive career across the sector has well-equipped him with the necessary tools to succeed in a competitive, fast-paced environment. “Since I began working for Mera Pharma, we have established a very strong finance team around the world, and installed relevant and perfect working places and systems,” he reflects. “We have increased our revenues by over 600% since 2017 and have created a very professional team and warm family atmosphere within the company.” Since his appointment as CFO, Jaroslaw has successfully led Mera Pharma from strength to strength. The financial expert leverages his industry knowledge and experience to effectively guide the company to elevated levels of prestige. For his remarkable achievements and dedication to Mera Pharma, Jaroslaw has been recognised as the CFO of the Year 2024 – Switzerland. We at Acquisition International would like to congratulate Jaroslaw on this achievement and would recommend keeping a close eye on this financial afficionado as he continues to achieve excellence. Contact: Jaroslaw Krupa Company: Mera Pharma GmbH Web Address: https://merapharmagmbh.com/ Mera Pharma is a Swiss pharmaceutical manufacturer and distributor of active pharmaceutical ingredients and pharmaceutical finished products. Producing high quality, affordable drugs, the company covers the entire production process, from development to manufacturing to distribution. Here, we speak with Mera Pharma’s Chief Financial Officer, Jaroslaw Krupa, following his recent award in the Worldwide Finance Awards 2024. E
RkJQdWJsaXNoZXIy MTUyMDQwMA==